These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4373594)

  • 21. [CO2 and the catecholamine content of the adrenal medulla of the rat].
    Lagneaux D; Lecomte J; Remacle R; Volon G
    C R Seances Soc Biol Fil; 1980; 174(5):905-10. PubMed ID: 6449272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Action of asphyxia on the catecholamine content of rat adrenals].
    Cession-Fossion A; Troquet J
    Arch Int Physiol Biochim; 1964 Sep; 72(4):661-5. PubMed ID: 4157800
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of anti-androgen treatment on the catecholamine synthetic pathway in the adrenal medulla of spontaneously hypertensive rats.
    Kumai T; Tanaka M; Tateishi T; Watanabe M; Nakura H; Asoh M; Kobayashi S
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):620-4. PubMed ID: 9686937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelin enhances and inhibits adrenal catecholamine release in deoxycorticosterone acetate-salt hypertensive rats.
    Lange DL; Haywood JR; Hinojosa-Laborde C
    Hypertension; 2000 Jan; 35(1 Pt 2):385-90. PubMed ID: 10642329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of nicotine on distribution and release of 14C-norepinephrine and 14C-dopamine in rat brain striatum and hypothalamus slices.
    Goodman FR
    Neuropharmacology; 1974 Nov; 13(10-11):1025-32. PubMed ID: 4437721
    [No Abstract]   [Full Text] [Related]  

  • 26. Stimulation of the catecholamine output of the isolated, perfused adrenal gland of the dog by angiotensin and bradykinin.
    Robinson RL
    J Pharmacol Exp Ther; 1967 May; 156(2):252-7. PubMed ID: 4290712
    [No Abstract]   [Full Text] [Related]  

  • 27. Morphological and biochemical observations on the catecholamine-storing vesicles of rat adrenomedullary cells during insulin-induced hypoglycemia.
    D'Anzi FA
    Am J Anat; 1969 Aug; 125(4):381-97. PubMed ID: 5822970
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of estrogens and progesterone on the catecholaminergic activity of the adrenal medulla in female rats.
    Fernández-Ruiz JJ; Bukhari AR; Martínez-Arrieta R; Tresguerres JA; Ramos JA
    Life Sci; 1988; 42(9):1019-28. PubMed ID: 3343893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular aspects of the storage and uptake of catecholamines.
    Kirshner N; Schanberg SM; Ferris RM
    Adv Drug Res; 1971; 6():121-56. PubMed ID: 4334740
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of atrial natriuretic peptide, angiotensin II and III on norepinephrine uptake in the rat adrenal medulla.
    Vatta MS; Bianciotti LG; Fernández BE
    Rev Esp Fisiol; 1992 Sep; 48(3):185-9. PubMed ID: 1301634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release of catecholamines from superfused bovine adrenal chromaffin cells cultured on microcarrier beads.
    Boarder MR; McArdle W
    J Neurochem; 1986 May; 46(5):1473-7. PubMed ID: 3958716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on catecholamine release and uptake in adreno-medullary storage granules.
    Lishajko F
    Acta Physiol Scand Suppl; 1971; 362():1-40. PubMed ID: 5284929
    [No Abstract]   [Full Text] [Related]  

  • 33. Desipramine-induced increase in efflux of endogenous dopamine from rat hypothalamus in vitro: mechanism and specificity.
    Myers SL; Tessel RE
    Neuropharmacology; 1983 May; 22(5):601-7. PubMed ID: 6877537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral oxytocin treatment affects the rat adreno-medullary catecholamine content modulating expression of vesicular monoamine transporter 2.
    Jovanovic P; Spasojevic N; Stefanovic B; Bozovic N; Jasnic N; Djordjevic J; Dronjak S
    Peptides; 2014 Jan; 51():110-4. PubMed ID: 24239562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term control of tyrosine hydroxylase.
    Carlsson A; Kehr W; Lindqvist M
    Adv Biochem Psychopharmacol; 1974; 12(0):135-42. PubMed ID: 4154020
    [No Abstract]   [Full Text] [Related]  

  • 36. The metabolic requirements from catecholamine release from the adrenal medulla.
    Rubin RP
    J Physiol; 1969 May; 202(1):197-209. PubMed ID: 5770885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catecholamine content of intracerebral adrenal medulla grafts.
    Freed WJ; Karoum F; Spoor HE; Morihisa JM; Olson L; Wyatt RJ
    Brain Res; 1983 Jun; 269(1):184-9. PubMed ID: 6683581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide modulates evoked catecholamine release from canine adrenal medulla.
    Barnes RD; Ward LE; Frank KP; Tyce GM; Hunter LW; Rorie DK
    Neuroscience; 2001; 104(4):1165-73. PubMed ID: 11457599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. α₂-Adrenoceptor-mediated inhibition of catecholamine release from the adrenal medulla of spontaneously hypertensive rats is preserved in the early stages of hypertension.
    Moura E; Pinto CE; Caló A; Serrão MP; Afonso J; Vieira-Coelho MA
    Basic Clin Pharmacol Toxicol; 2011 Oct; 109(4):253-60. PubMed ID: 21518261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The release of catecholamines from the adrenal medulla by peptides.
    Staszewska-Barczak J; Vane JR
    Br J Pharmacol Chemother; 1967 Aug; 30(3):655-67. PubMed ID: 4292940
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.